β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Protein
Deling Yin1, Xiaohua Yang2, Hui Li2
1From the Department of Internal Medicine, College of Medicine, East Tennessee State University, Johnson City, Tennessee 37604 and yin@etsu.edu.
Abstract:
Recent studies reveal that multifunctional protein β-arrestin 2 (Arrb2) modulates cell apoptosis. Survival and various aspects of liver injury were investigated in WT and Arrb2 KO mice after bile duct ligation (BDL). We found that deficiency of Arrb2 enhances survival and attenuates hepatic injury and fibrosis. Following BDL, Arrb2-deficient mice as compared with WT controls displayed a significant reduction of hepatocyte apoptosis as demonstrated by the TUNEL assay. Following BDL, the levels of phospho-Akt and phospho-glycogen synthase kinase 3β (GSK3β) in the livers were significantly increased in Arrb2 KO compared with WT mice, although p-p38 increased in WT but not in Arrb2-deficient mice. Inhibition of GSK3β following BDL decreases hepatic apoptosis and decreased p-p38 in WT mice but not in Arrb2 KO mice. Activation of Fas receptor with Jo2 reduces phospho-Akt and increases apoptosis in WT cells and WT mice but not in Arrb2-deficient cells and Arrb2-deficient mice. Consistent with direct interaction of Arrb2 with and regulating Akt phosphorylation, the expression of a full-length or N terminus but not the C terminus of Arrb2 reduces Akt phosphorylation and coimmunoprecipates with Akt. These results reveal that the protective effect of deficiency of Arrb2 is due to loss of negative regulation of Akt due to BDL and decreased downstream GSK3β and p38 MAPK signaling pathways.
Insights
Losing β-arrestin 2 (Arrb2) protein improves survival and reduces liver injury after bile duct ligation. Arrb2 deficiency protects against hepatocyte apoptosis by increasing Akt signaling.
Area of Science:
- Hepatology
- Molecular Biology
- Cellular Signaling
Background:
- The protein β-arrestin 2 (Arrb2) plays a role in modulating cell apoptosis.
- Understanding Arrb2's function in liver injury is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate the role of Arrb2 in liver injury and fibrosis following bile duct ligation (BDL).
- To elucidate the molecular mechanisms by which Arrb2 influences hepatocyte apoptosis and survival.
Main Methods:
- Comparison of survival, hepatic injury, and fibrosis in wild-type (WT) and Arrb2 knockout (KO) mice after BDL.
- Assessment of hepatocyte apoptosis using TUNEL assay.
- Analysis of key signaling pathway proteins including Akt, GSK3β, and p38 MAPK.
- In vitro studies using cell lines to examine Arrb2's interaction with Akt.
Main Results:
- Arrb2-deficient mice exhibited enhanced survival and attenuated liver injury and fibrosis post-BDL.
- Hepatocyte apoptosis was significantly reduced in Arrb2 KO mice compared to WT controls.
- Arrb2 deficiency led to increased Akt and GSK3β phosphorylation, while p38 MAPK phosphorylation was increased in WT but not KO mice.
- Arrb2 directly interacts with Akt, regulating its phosphorylation.
Conclusions:
- Deficiency of Arrb2 confers protection against liver injury and fibrosis following BDL.
- The protective effect is attributed to the loss of negative regulation of Akt signaling, leading to decreased downstream GSK3β and p38 MAPK activation.
- Arrb2 is a key regulator of Akt phosphorylation and plays a critical role in hepatocyte apoptosis during liver injury.
More Related Videos
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
01:20The JAK-STAT Signaling Pathway
01:22Amplifying Signals via Enzymatic Cascade
01:31The Intrinsic Apoptotic Pathway
01:12GPCR Desensitization
01:25cAMP-dependent Protein Kinase Pathways